vinflunine,erdafitinib,Docetaxel
pierre fabre,janssen
['urothelial carcinoma', 'urothelial', 'vinflunine', 'erdafitinib']
erdafitinib os (hr 0.64, median 12.1 vs. 7.8 mo) and pfs (hr 0.58, median 5.6 vs. 2.7 mo) compared with doce/vinflunine in fgfr3+ metastatic urothelial carcinoma pts after with platinum-based chemo and io. #asco2023
Medical Oncologist MD, PhD @rededor; Chief, GU Med Onc Service @icesp_; former clinical fellow @mskcc. Views=my own. RTs≠endorsements. #GU_Oncology